Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation-wide multicenter study.
Fengzhu GuoZongbi YiWenna WangYi-Qun HanPei YuSu ZhangQuchang OuyangMin YanXiaojia WangXichun HuZefei JiangTao HuangZhongsheng TongShu-Sen WangYongmei YinHui LiRunxiang YangHuawei YangYuee TengTao SunLi CaiHongyuan LiXi ChenJianjun HeXinlan LiuShune YangJinhu FanYou Lin QiaoJiayu WangBing-He XuPublished in: Cancer medicine (2021)
Taken together, ABC remained the mainstay of breast cancer treatment, especially in neo and adjuvant therapy. ABC was mainly used as a combination therapy, and the correlation between influencing factors and ABC choice varied during different settings, indicating the preference and different perspectives of medication considered by medical oncologists regarding the use ABC in China.